Back to News
Market Impact: 0.1
MacroGenics, Inc. Appoints Michael Vasconcelles and Emil Kuriakose to Board of Directors
Source: Nasdaq
Management & GovernanceHealthcare & Biotech
MacroGenics’ board approved increasing its size from 10 to 11 members, effective October 30, 2026, and appointed Michael Vasconcelles following a recommendation from its Nominating and Governance Committee. The article text ends before specifying the role he will serve.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Inside the chip talent war: Trade secrets and rising Chinese rivals
- LIV Golf faces liquidation after BC Partners scraps rescue plan
- Google expands voluntary buyouts to 5 countries as AI spending fuels cost cuts
- CVS Plans to Break Up $117 Billion Healthcare Conglomerate
- How Abdul El-Sayed would build Medicare for All, from a wealth tax to a Fed-style governing board
- BillionToOne SVP John ten Bosch sells $320,723 in stock